Latest Publications

@article{andrysik_aryl_2013,

title = {Aryl hydrocarbon receptor-mediated disruption of contact inhibition is associated with connexin43 downregulation and inhibition of gap junctional intercellular communication.},

author = {Zdeněk Andrysík and Jiřina Procházková and Markéta Kabátková and Lenka Umannová and Pavlína Simečková and Jiří Kohoutek and Alois Kozubík and Miroslav Machala and Jan Vondráček},

doi = {10.1007/s00204-012-0963-7},

issn = {1432-0738 0340-5761},

year  = {2013},

date = {2013-03-01},

journal = {Archives of toxicology},

volume = {87},

number = {3},

pages = {491–503},

abstract = {The aryl hydrocarbon receptor (AhR) contributes to the control of cell-to-cell communication, cell adhesion, migration or proliferation. In the present study, we investigated the regulation of connexin43 (Cx43) and Cx43-mediated gap junctional intercellular communication (GJIC) during the AhR-dependent disruption of contact inhibition in non-tumorigenic liver epithelial cells. The contact inhibition of cell proliferation is a process restricting the cell division of confluent non-transformed cells, which is frequently abolished in cancer cells; however, the mechanisms contributing to its disruption are still only partially understood. Disruption of contact inhibition, which was induced by toxic AhR ligands 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or polycyclic aromatic hydrocarbons in epithelial WB-F344 cells, reduced Cx43 protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner. Although both intracellular and membrane Cx43 pools were markedly reduced in cells released from contact inhibition by TCDD, siRNA-mediated Cx43 knock-down was not sufficient to stimulate proliferation in contact-inhibited cells. Our data suggest that downregulation of Cx43/GJIC in non-transformed epithelial cells is an inherent part of disruption of contact inhibition, which occurs at the post-transcriptional level. This process runs in parallel with alterations of other forms of cell-to-cell communication, thus suggesting that toxic AhR agonists may simultaneously abrogate contact inhibition and reduce GJIC, two essential mechanisms linked to deregulation of cell-to-cell communication during tumor promotion and progression.},

note = {Place: Germany},

keywords = {Animals, Aryl Hydrocarbon/*agonists/genetics/metabolism, Benz(a)Anthracenes/toxicity, Carcinogens/*toxicity, Cell Communication/*drug effects, Cell Line, Cell Proliferation, Cell Transformation, Connexin 43/genetics/*metabolism, Contact Inhibition/*drug effects, Dose-Response Relationship, Down-Regulation, Drug, Epithelial Cells/*drug effects/metabolism/pathology, Fluorenes/toxicity, Gap Junctions/*drug effects/metabolism/pathology, Gene Knockdown Techniques, Indoles/pharmacology, Ligands, Liver Neoplasms/chemically induced/metabolism/pathology, Liver/*drug effects/metabolism/pathology, Neoplastic/chemically induced/metabolism/pathology, Phloroglucinol/analogs & derivatives/pharmacology, Phosphorylation, Polychlorinated Dibenzodioxins/toxicity, Proteasome Endopeptidase Complex/metabolism, Rats, Receptors, RNA Interference, Signal Transduction/*drug effects, Time Factors, Transfection},

pubstate = {published},

tppubtype = {article}

}

@article{gabelova_genotoxicity_2011,

title = {Genotoxicity of 7H-dibenzo[c,g]carbazole and its tissue-specific derivatives in human hepatoma HepG2 cells is related to CYP1A1/1A2 expression.},

author = {Alena Gábelová and Zuzana Valovičová and Monika Mesárošová and Lenka Trilecová and Eva Hrubá and Soňa Marvanová and Pavel Krčmár and Alena Milcová and Jana Schmuczerová and Jan Vondráček and Miroslav Machala and Jan Topinka},

doi = {10.1002/em.20664},

issn = {1098-2280 0893-6692},

year  = {2011},

date = {2011-10-01},

journal = {Environmental and molecular mutagenesis},

volume = {52},

number = {8},

pages = {636–645},

abstract = {The goal of this study was to investigate the genotoxicity of 7H-dibenzo[c,g]carbazole (DBC), a ubiquitous environmental pollutant, and its methyl derivatives, 5,9-dimethylDBC (DiMeDBC), a strict hepatocarcinogen, and N-methylDBC (N-MeDBC), a specific sarcomagen in human hepatoma HepG2 cells, and to infer potential mechanisms underlying the biological activity of particular carcinogen. All dibenzocarbazoles, regardless the tissue specificity, induced significant DNA strand break levels and micronuclei in HepG2 cells; though a mitotic spindle dysfunction rather than a chromosome breakage was implicated in N-MeDBC-mediated micronucleus formation. While DBC and N-MeDBC produced stable DNA adducts followed with p53 protein phosphorylation at Ser-15, DiMeDBC failed. A significant increase in DNA strand breaks following incubation of exposed cells with a repair-specific endonuclease (Fpg protein) suggested that either oxidative DNA damage or unstable DNA-adducts might underlie DiMeDBC genotoxicity in human hepatoma cells. DiMeDBC and N-MeDBC increased substantially also the amount of CYP1A1/2 expression in HepG2 cells. Pretreatment of cells with substances affecting AhR-mediated CYP1A family of enzymes expression; however, diminished DiMeDBC and N-MeDBC genotoxicity. Our data clearly demonstrated differences in the mechanisms involved in the biological activity of DiMeDBC and N-MeDBC in human hepatoma cells; the genotoxicity of these DBC derivatives is closely related to CYP1A1/2 expression.},

note = {Place: United States},

keywords = {Base Sequence, Blotting, Carbazoles/*toxicity, Cell Survival/drug effects, Chromosome-Defective/chemically induced/statistics & numerical data, Comet assay, Cytochrome P-450 CYP1A1/*genetics, Cytochrome P-450 CYP1A2/*genetics, DNA adducts, DNA Breaks, Dose-Response Relationship, Drug, Hep G2 Cells, Histones/metabolism, Humans, Micronuclei, Micronucleus Tests, Mitotic Index, Molecular Sequence Data, Mutagens/*toxicity, Phosphorylation, Real-Time Polymerase Chain Reaction, Tumor Suppressor Protein p53/metabolism, Western},

pubstate = {published},

tppubtype = {article}

}

@article{starsichova_tgf-beta1_2010,

title = {TGF-beta1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells.},

author = {Andrea Starsíchová and Eva Lincová and Zuzana Pernicová and Alois Kozubík and Karel Soucek},

doi = {10.1016/j.cellsig.2010.06.014},

issn = {1873-3913 0898-6568},

year  = {2010},

date = {2010-11-01},

journal = {Cellular signalling},

volume = {22},

number = {11},

pages = {1734–1744},

abstract = {Chronic inflammation plays an important role in the initiation and progression of various human diseases including benign prostatic hyperplasia or prostate cancer. Here we show that the proinflammatory cytokine interleukin-6 (IL-6) has prosurvival effects and chronically activates the Jak2/STAT3 signalling pathway in a model of benign prostatic hyperplasia (BPH-1). We demonstrate that the antiinflammatory cytokine transforming growth factor-beta1 (TGF-beta1), which also permanently activates its canonical signalling pathway through SMAD proteins in BPH-1 cells, modifies the effects of IL-6 on cell proliferation. Importantly, TGF-beta1 inhibits IL-6 signal transduction by decreasing the phosphorylation levels of STAT3. This effect is associated with decreased expression of Jak2 at both mRNA and protein levels. Moreover, we showed that TGF-beta1 inhibits IL-6-induced expression of the cancer-associated gene MUC1. These observations demonstrated a novel interaction between TGF-beta1 and IL-6 signalling and suggested another mechanism of how defects in TGF-beta signalling, frequently associated with prostate pathologies, can contribute to the disruption of tissue homeostasis.},

note = {Place: England},

keywords = {Cell Line, Cell Proliferation, Epithelial Cells/*metabolism, Humans, Interleukin-6/*antagonists & inhibitors/pharmacology, Janus Kinase 2/genetics/*metabolism, Male, Mucin-1/metabolism, Phosphorylation, Prostate/cytology/enzymology/*metabolism, Prostatic Hyperplasia/enzymology/*metabolism, RNA, RNA Interference, Signal Transduction, Smad Proteins/metabolism, Small Interfering/metabolism, STAT3 Transcription Factor/*metabolism, Transforming Growth Factor beta1/*pharmacology},

pubstate = {published},

tppubtype = {article}

}

@article{kummer_estrogenic_2008,

title = {Estrogenic activity of environmental polycyclic aromatic hydrocarbons in uterus of immature Wistar rats.},

author = {Vladimír Kummer and Jarmila Masková and Zdenek Zralý and Jirí Neca and Pavlína Simecková and Jan Vondrácek and Miroslav Machala},

doi = {10.1016/j.toxlet.2008.06.862},

issn = {0378-4274},

year  = {2008},

date = {2008-08-01},

journal = {Toxicology letters},

volume = {180},

number = {3},

pages = {212–221},

abstract = {Polycyclic aromatic hydrocarbons (PAHs) are an important group of environmental pollutants, known for their mutagenic and carcinogenic activities. Many PAHs are aryl hydrocarbon receptor (AhR) ligands and several recent studies have suggested that PAHs or their metabolites may activate estrogen receptors (ER). The present study investigated possible estrogenic/antiestrogenic effects of abundant environmental contaminants benzo[a]pyrene (BaP), benz[a]anthracene (BaA), fluoranthene (Fla) and benzo[k]fluoranthene (BkF) in vivo, using the immature rat uterotrophic assay. The present results suggest that BaA, BaP and Fla behaved as estrogen-like compounds in immature Wistar rats, when applied for 3 consecutive days at 10mg/kg/day, as documented by a significant increase of uterine weight and hypertrophy of luminal epithelium. These effects were likely to be mediated by ERalpha, a major subtype of ER present in uterus, as they were inhibited by treatment with ER antagonist ICI 182,780. BaA, the most potent of studied PAHs, induced a significant estrogenic effect within a concentration range 0.1-50mg/kg/day; however, it did not reach the maximum level induced by reference estrogens. The proposed antiestrogenicity of the potent AhR agonist BkF was not confirmed in the present in vivo study; the exposure to BkF did not significantly affect the uterine weight, although a weak suppression of ERalpha immunostaining was observed in luminal and glandular epithelium, possibly related to its AhR-mediated activity. The PAHs under study did not induce marked genotoxic damage in uterine tissues, as documented by the lack of Ser-15-phoshorylated p53 protein staining. With the exception of Fla, all three remaining compounds increased CYP1-dependent monooxygenation activities in liver at the doses used, suggesting that the potential tissue-specific antiestrogenic effects of PAHs mediated by metabolization of 17beta-estradiol also cannot be excluded. Taken together, these environmentally relevant PAHs induced estrogenic effects in vivo, which might affect their toxic impact and carcinogenicity.},

note = {Place: Netherlands},

keywords = {Animals, Cytochrome P-450 CYP1A1/metabolism, Endocrine Disruptors/*toxicity, Environmental Pollutants/*toxicity, Epithelium/drug effects, Estradiol/metabolism, Estrogen Receptor alpha/metabolism, Estrogens/*biosynthesis, Female, Hydroxylation, Immunohistochemistry, Liver/drug effects/metabolism, Microsomes, Organ Size/drug effects, Ovary/drug effects, Phosphorylation, Polycyclic Aromatic Hydrocarbons/*toxicity, Rats, Tumor Suppressor Protein p53/metabolism, Uterus/drug effects/*metabolism, Wistar},

pubstate = {published},

tppubtype = {article}

}

@article{upham_tumor_2008,

title = {Tumor promoting properties of a cigarette smoke prevalent polycyclic aromatic hydrocarbon as indicated by the inhibition of gap junctional intercellular communication via phosphatidylcholine-specific phospholipase C.},

author = {Brad L. Upham and Ludek Bláha and Pavel Babica and Joon-Suk Park and Iva Sovadinova and Charles Pudrith and Alisa M. Rummel and Liliane M. Weis and Kimie Sai and Patti K. Tithof and Miodrag Guzvić and Jan Vondrácek and Miroslav Machala and James E. Trosko},

doi = {10.1111/j.1349-7006.2008.00752.x},

issn = {1349-7006 1347-9032},

year  = {2008},

date = {2008-04-01},

journal = {Cancer science},

volume = {99},

number = {4},

pages = {696–705},

abstract = {Inhibition of gap junctional intercellular communication (GJIC) and the activation of intracellular mitogenic pathways are common hallmarks of epithelial derived cancer cells. We previously determined that the 1-methyl and not the 2-methyl isomer of anthracene, which are prominent cigarette smoke components, activated extracellular receptor kinase, and inhibited GJIC in WB-F344 rat liver epithelial cells. Using these same cells, we show that an immediate upstream response to 1-methylanthracene was a rapid (<1 min) release of arachidonic acid. Inhibition of phosphatidylcholine-specific phospholipase C prevented the inhibition of GJIC by 1-methylanthracene. In contrast, inhibition of phosphatidylinositol specific phospholipase C, phospholipase A(2), diacylglycerol lipase, phospholipase D, protein kinase C, and tyrosine protein kinases had no effect on 1-methylanthracene-induced inhibition of GJIC. Inhibition of protein kinase A also prevented inhibition of GJIC by 1-methylanthracene. Direct measurement of phosphatidylcholine-specific phospholipase C and sphingomyelinase indicated that only phosphatidylcholine-specific phospholipase C was activated in response to 1-methylanthracene, while 2-methylanthracene had no effect. 1-methylanthracene also activated p38-mitogen activated protein kinase; however, like extracellular kinase, its activation was not involved in 1-methylanthracene-induced regulation of GJIC, and this activation was independent of phosphatidylcholine-specific phospholipase C. Although mitogen activated protein kinases were activated, Western blot analyzes indicated no change in connexin43 phosphorylation status. Our results indicate that phosphatidylcholine-specific phospholipase C is an important enzyme in the induction of a tumorigenic phenotype, namely the inhibition of GJIC; whereas mitogen activated protein kinases triggered in response to 1-methylanthracene, were not involved in the deregulation of GJIC.},

note = {Place: England},

keywords = {Animals, Anthracenes/chemistry/*toxicity, Carcinogens, Cell Communication/drug effects, Cell Line, Connexin 43/analysis/metabolism, Connexins/metabolism, Environmental/*toxicity, Enzyme Inhibitors/pharmacology, Gap Junctions/chemistry/*drug effects/metabolism, Neoplasms/chemically induced/enzymology, Nicotiana/toxicity, p38 Mitogen-Activated Protein Kinases/metabolism, Phosphorylation, Rats, Smoke, Sphingomyelin Phosphodiesterase/analysis/metabolism, Type C Phospholipases/antagonists & inhibitors/*metabolism},

pubstate = {published},

tppubtype = {article}

}

@article{soucek_transforming_2006,

title = {Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis.},

author = {Karel Soucek and Jirí Pacherník and Lukás Kubala and Jan Vondrácek and Jirina Hofmanová and Alois Kozubík},

doi = {10.1016/j.leukres.2005.09.007},

issn = {0145-2126},

year  = {2006},

date = {2006-05-01},

journal = {Leukemia research},

volume = {30},

number = {5},

pages = {607–623},

abstract = {The interaction between retinoids and transforming growth factor-beta1 (TGF-beta1) leading to regulation of proliferation, differentiation and apoptosis is not still fully understood. In this study, we demonstrated that a combination treatment with all-trans retinoic acid (ATRA) and TGF-beta1 led to the enhancement of ATRA-induced suppression of cell proliferation, which is accompanied by inhibition of ATRA-induced apoptosis in human leukemia HL-60 cells. This effect was preceded by the arrest of cells in G0/G1 cell cycle phase linked with pRb protein dephosphorylation, continuous accumulation of p21 and transiently increased level of p27, inhibitors of cyclin-dependent kinases. Inhibition of ATRA-induced apoptosis by TGF-beta1 was associated with an increased level of Mcl-1 protein, an anti-apoptotic member of Bcl-2 family, but not with inhibition of mitochondrial membrane depolarization. Levels of other Bcl-2 family proteins (Bcl-2, Bcl-X(L), Bad, Bak, Bax) were unaffected by simultaneous ATRA and TGF-beta1 treatment, when compared to ATRA alone. Upregulation of c-FLIP(L) protein, an inhibitor of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), correspond with inhibition of ATRA-induced (autocrine TRAIL-mediated) caspase-8 activation and apoptosis. These results suggest that apoptosis inhibition associated with proliferation block could depend on modulation of the TRAIL apoptotic pathway and regulation of the Mcl-1 protein level. In summary, we demonstrate that the balance of processes leading to regulation of proliferation and differentiation of myeloid cells can modulate cell sensitivity to apoptosis-inducing stimuli.},

note = {Place: England},

keywords = {Apoptosis Regulatory Proteins/metabolism/pharmacology, Apoptosis/*drug effects/physiology, bcl-2-Associated X Protein/drug effects/metabolism, CASP8 and FADD-Like Apoptosis Regulating Protein, Caspase 3, Caspase 8, Caspases/drug effects/metabolism, CD11b Antigen/biosynthesis/drug effects, Cell Cycle/drug effects, Cell Differentiation/drug effects, Cell Proliferation/drug effects, Cell Survival/drug effects, Cultured, Cyclin-Dependent Kinase Inhibitor p21/biosynthesis/drug effects, Drug Synergism, Enzyme Activation/drug effects, G1 Phase/drug effects, Granulocytes/drug effects/physiology, HL-60 Cells, Humans, Intracellular Signaling Peptides and Proteins/drug effects/metabolism, Membrane Glycoproteins/metabolism/pharmacology, Mitochondrial Membranes/drug effects/physiology, Myeloid Cell Leukemia Sequence 1 Protein, Neoplasm Proteins/drug effects/metabolism, Phosphorylation, Proto-Oncogene Proteins c-bcl-2/drug effects/metabolism, Reactive Oxygen Species/metabolism, Resting Phase, Retinoblastoma Protein/drug effects/metabolism, TNF-Related Apoptosis-Inducing Ligand, Transforming Growth Factor beta/*pharmacology, Transforming Growth Factor beta1, Tretinoin/*antagonists & inhibitors/pharmacology, Tumor Cells, Tumor Necrosis Factor-alpha/metabolism/pharmacology},

pubstate = {published},

tppubtype = {article}

}

@article{andrysik_activation_2006,

title = {Activation of ERK1/2 and p38 kinases by polycyclic aromatic hydrocarbons in rat liver epithelial cells is associated with induction of apoptosis.},

author = {Zdenek Andrysík and Miroslav Machala and Katerina Chramostová and Jirina Hofmanová and Alois Kozubík and Jan Vondrácek},

doi = {10.1016/j.taap.2005.06.007},

issn = {0041-008X},

year  = {2006},

date = {2006-03-01},

journal = {Toxicology and applied pharmacology},

volume = {211},

number = {3},

pages = {198–208},

abstract = {Deregulation of various signaling pathways, linked either to induction of cell proliferation or to modulation of cellular differentiation and apoptosis, has been proposed to contribute to carcinogenicity of polycyclic aromatic hydrocarbons (PAHs). In the present study, we investigated effects of the PAHs previously shown to induce cell proliferation and/or apoptosis in contact-inhibited rat liver epithelial WB-F344 cells, with an aim to define the role of mitogen-activated protein kinases in both events. We found that only strong genotoxin dibenzo[a,l]pyrene (DBalP) activated extracellular signal-regulated kinases 1 and 2 (ERK1/2) and p38 kinase, but not c-Jun N-terminal kinases (JNKs), at concentrations inducing both apoptosis and phosphorylation of p53 tumor suppressor at serine 15 residue. In contrast, the PAHs stimulating cell proliferation in WB-F344 cell line had no effect on activation of ERK1/2, p38 or JNKs. Synthetic inhibitors of ERK1/2 activation (U0126) or p38 kinase activity (SB203580) prevented both apoptosis and induction of p53 phosphorylation by DBalP. Pifithrin-alpha, inhibitor of p53 transcriptional activity, prevented induction of apoptosis and activation of ERK1/2 and p38. Taken together, our data suggest that both ERK1/2 and p38 are activated in response to DBalP and that they might be involved in regulation of cellular response to DNA damage induced by DBalP, while neither kinase is involved in the release from contact inhibition induced by PAHs.},

note = {Place: United States},

keywords = {*Epithelial Cells/cytology/drug effects/enzymology, *Liver/cytology/drug effects/enzymology, Animals, Apoptosis/*drug effects, Cell Cycle/drug effects, Cell Line, Cell Proliferation/drug effects, Enzyme Activation/drug effects, Enzyme Inhibitors/pharmacology, Extracellular Signal-Regulated MAP Kinases/*metabolism, JNK Mitogen-Activated Protein Kinases/metabolism, p38 Mitogen-Activated Protein Kinases/*metabolism, Phosphorylation, Polycyclic Aromatic Hydrocarbons/*toxicity, Rats},

pubstate = {published},

tppubtype = {article}

}